Transferrin receptor (CD71) is a marker of poor prognosis in breast cancer and can predict response to tamoxifen

Authors: Hany Onsy Habashy, Desmond G. Powe, Cindy M. Staka, Emad A. Rakha, Graham Ball, Andrew R. Green, Mohammed A. Aleskandarany, Emma C. Paish, R. Douglas Macmillan, Robert I. Nicholson, Ian O. Ellis, Julia M.W. Gee - Breast Cancer Research and Treatment 2009 cited by 239